Workflow
药品
icon
Search documents
引入“随手拍”打击坑老骗老,增进大众参与
Nan Fang Du Shi Bao· 2025-05-29 07:54
Core Viewpoint - The National Market Supervision Administration has initiated a nationwide special rectification campaign to combat false advertising of drugs and health products targeting the elderly, addressing long-standing issues of exploitation in this market segment [1][3]. Group 1: Regulatory Actions - The campaign includes the "You Shoot, We Check" initiative, encouraging the public to report suspected illegal activities by capturing evidence [1][4]. - The initiative aims to enhance public participation in monitoring and reporting violations, responding to societal expectations for more effective regulatory intervention [4]. Group 2: Market Context - There is a growing concern over the exploitation of elderly consumers, particularly in the context of the digital economy, where their limited digital skills make them vulnerable to scams [1][2]. - Various institutions are targeting the elderly demographic, utilizing emotional marketing and exaggerated claims about product efficacy to drive sales [2][3]. Group 3: Responsibilities of Platforms - Online platforms have a responsibility to monitor and manage the information and services offered by their operators, as mandated by the "Network Transaction Supervision Management Measures" [3]. - Offline venues, such as senior universities and care service institutions, also bear significant responsibility for ensuring the integrity of their activities and the information they disseminate [3].
我省全方位支持医药产业创新发展
Liao Ning Ri Bao· 2025-05-29 00:46
Group 1 - The pharmaceutical industry is a key emerging sector in the province, with a focus on regulatory reforms to enhance development [1] - Nine new policy documents have been issued this year to empower high-quality development in the pharmaceutical industry, including nine newly approved drug registration numbers and 19 traditional Chinese medicine formula granules [1] - A pilot program for optimizing drug supplementary application review and approval procedures will be established in Liaoning, significantly reducing technical review timelines from 200 working days to 60 [1] Group 2 - The province supports innovation in pharmaceuticals and medical devices by optimizing review and approval processes, which has led to a reduction of over 3,600 working days in enterprise inspections [2] - New policies have adjusted industry entry conditions, such as reducing the required warehouse area for new pharmaceutical wholesale enterprises by 50%, resulting in cost savings for companies [2] - The implementation of remote pharmaceutical services has helped reduce operational costs for enterprises by approximately 34 million yuan annually [2] Group 3 - The province has introduced a new safety assessment standard for ordinary cosmetics, reducing testing costs by over 60%, leading to a 950% increase in the submission of complete safety assessment materials [3] - Collaborative efforts have been made to establish medical device innovation service stations, providing comprehensive support for enterprises in policy consultation, application guidance, and training [3] - The initiative aims to enhance the local business environment and attract investment, promoting the high-quality development of the medical device industry [3]
中国整治保健品市场“坑老”“骗老”行为
Zhong Guo Xin Wen Wang· 2025-05-28 07:25
Group 1 - The core viewpoint of the articles is that the Chinese National Market Supervision Administration is launching a special campaign to combat false advertising of drugs and health products targeting the elderly, addressing the issue of "scamming the elderly" in the market [1][2] - The campaign will focus on the increasing prevalence of online marketing tactics, such as live streaming and social media, which are being used to mislead elderly consumers through promises of free trials and exaggerated health claims [1] - Specific tasks outlined in the campaign include cracking down on misleading promotions disguised as expert consultations and health advice, as well as the sale of pseudo-high-tech products and health supplements [1] Group 2 - The campaign will enhance the regulation of advertisements related to drugs and health products for the elderly, ensuring strict adherence to advertising review systems and penalizing disguised advertisements that promote health knowledge [2] - There will be a prohibition on health products claiming to treat diseases, aiming to prevent the phenomenon of health products being marketed as "miracle drugs" [2] - Food safety supervision will be strengthened, focusing on the investigation of false information in food and health product labels, particularly regarding disease prevention and treatment claims [2]
美国5月关税已超200亿美元 仍难补减税新政带来的天量赤字
智通财经网· 2025-05-28 02:48
智通财经APP获悉,美国财政部数据显示,特朗普总统的关税政策在5月持续冲击进口商,当月"关税及特定消费税"收入已突破223亿美元。这一月度总额在 未来几天可能仅会小幅上升,因进口商通常集中在单日缴纳关税——5月22日国库曾单日入账逾165亿美元。 截至目前的5月关税收入已超过4月全月的174亿美元,更远超3月的96亿美元。 这延续了特朗普第二任期以来的财政收入激增态势,其规模不仅碾压近年历史,也远超其首个总统任期。自1月1日以来,国库累计关税收入已超920亿美 元。 5月收入激增源于特朗普最大规模关税(4月5日起对全球几乎所有国家加征10%关税)首次完整月度生效。尽管特朗普本月对中国降低部分关税、对英国有限度 减税,但收入仍创新高。 四月份大量所得税申报表为政府金库带来了超过 8500 亿美元的收入。 近几十年来,关税收入往往占联邦收入的2%左右。近几个月的激增仅略微改变了这一状况,目前关税收入占比已接近4%。 特朗普周二在社交媒体发文暗示可能加征更多关税,谈及暂缓对欧50%关税时称:"记住,若无法达成协议,我有权'设定'对美贸易条款。" 未来数月特朗普还威胁出台新关税,包括针对半导体、药品等行业的专项关税, ...
特朗普关税谈判:想法很多,执行拉垮
Hu Xiu· 2025-05-28 01:50
1)把中国和其他国家分开,先易后难,尝试谈妥其他国家后再以优势地位开启对华谈判。 2)把安全问题与贸易问题进行捆绑,找控制力最强、对美最依赖且具有代表意义的日本、韩国来打样。 3)各方为了降低关税,必须从不同角度对美让利,如:扩大进口美货、增加对美投资、承担更多军费分摊义务 等,但美方不会取消10%的基准关税,且涉及特定行业的关税需一事一议。 想法很美好,落地却困难。 美国最初制定的关税谈判策略大致是这样的: 经过近两个月紧锣密鼓的磋商,特朗普政府一共只达成了两项拿得出手的协议:一个是5月8日美国和英国就贸易 框架达成一致,另一个是5月13日美国和中国宣布90天缓期。 近期有西方媒体报道,通过与各国贸易谈判官员以及美国商界领袖进行沟通,发现许多会谈中的分歧越来越大, 包括那些急于达成协议的政府,也意识到对美贸易谈判将是一场持久战。 据专业媒体分析,现阶段最有可能与特朗普政府达成协议的国家是印度和越南。 其中,美印协议更像是一个未来谈判的框架,有可能在6月份落地;而越南因面临46%的高关税,且对美出口关乎 经济命脉,因此最有可能做出重大让步。 除此之外,日本7月份要举行参议院选举,石破茂政府如果能谈出一个漂亮协 ...
打击药品、保健品市场“坑老”“骗老” 专项整治开启
news flash· 2025-05-28 01:32
Core Viewpoint - The National Market Supervision Administration has launched a special campaign to combat fraudulent practices targeting the elderly in the pharmaceutical and health product markets [1] Group 1: Regulatory Actions - Local market supervision departments will focus on the pharmaceutical and health product sectors for the elderly, addressing false advertising, price fraud, illegal advertisements, and illegal additives that infringe on the rights of the elderly and disrupt market competition [1] - The campaign includes a "You Shoot, We Check" initiative, encouraging the public to report suspected illegal activities by capturing evidence, which will help in the timely collection and handling of violations [1] Group 2: Objectives - The initiative aims to protect the legitimate rights of the elderly and continuously optimize the market competition environment [1]
如何看待特朗普对欧盟50%的关税威胁?
HTSC· 2025-05-26 02:25
Market Reaction - Following Trump's announcement, the US experienced a significant decline in stocks, bonds, and the dollar, with the dollar index dropping by 0.8% and the euro strengthening by 0.7%[2] - European stock indices, particularly France's CAC40 and Germany's DAX, fell by 1.9% and 1.5% respectively, while the S&P 500 index in the US decreased by 0.7%[2] - The 10-year Eurozone bond yield increased by 1.4 basis points, while the 10-year US Treasury yield fell by 2.3 basis points, indicating market volatility[2] Tariff Implications - Trump's proposed 50% tariff on the EU could lead to significant economic repercussions for both the US and EU, as they are each other's largest trading partners[4] - In 2024, the US accounted for 14% of EU imports and 21% of EU exports, while the EU represented 18% of US imports and 19% of US exports[4] - If implemented, the US could see a reduction of over 50% in imports from the EU, severely impacting industries such as pharmaceuticals, machinery, and automobiles[4] Economic Context - The US faces increasing pressure from rising Treasury yields, which could limit the effectiveness of its tariff policies and lead to greater asset sell-off[5] - The US Treasury yields for 10-year and 30-year bonds have recently surpassed 4.5% and 5.0% respectively, reflecting concerns over fiscal sustainability[5][6] - The EU has more room for fiscal expansion compared to the US, which may lead to a more favorable economic outlook for Europe in the face of potential tariffs[5] Political Dynamics - Trump's tariff threats may be more of a strategic maneuver in trade negotiations with the EU, especially given the slow progress in recent talks[3] - The political landscape in the US may limit Trump's ability to implement the proposed tariffs, as domestic pressures could shift focus away from international trade issues[7] - The likelihood of the 50% tariff being enacted is low, with expectations that the final tariff level will not exceed 20%[8]
经济热点问答|美方威胁对欧盟征收高关税意欲何为?
Xin Hua She· 2025-05-24 11:41
美国总统特朗普23日威胁自6月1日起对进口自欧盟的商品征收50%关税,远高于美国此前宣布对欧暂缓 的20%所谓"对等关税",招致欧盟方面强烈不满并引发资本市场再次动荡。美欧贸易磋商仍在进行中, 美方为何突然提议对欧加征高额关税?欧盟方面将如何应对?美欧关税博弈将产生哪些影响? 美方为何再次威胁? 特朗普当天在社交媒体上表示,欧盟在贸易方面"很难打交道",美欧贸易磋商"毫无进展"。因此,他建 议自6月1日起对进口自欧盟的商品征收50%关税。《华盛顿邮报》援引欧洲消息人士的话报道,这一关 税威胁令欧盟方面"措手不及"。 分析人士认为,这一表态显示美方不满谈判进展。美国财政部长贝森特当天也表示,对欧盟方面给出的 方案不满意,而且欧盟"存在集体行动问题"。有美国媒体援引欧洲国家官员的话报道,美方要求欧盟单 方面让步,却几乎没有提供任何回报,给欧盟出了难题,因为任何欧盟成员对谈判结果不满都会阻止或 拖延协议通过。 现阶段,美欧在贸易领域分歧较大,欧盟有意在购买美国天然气、武器和农产品方面作出让步,但不会 接受美国有关取消增值税、削弱数字监管和税收以及降低食品标准的要求。 另外,有分析认为,美国政府对当前美欧关系并不满意 ...
港股午评:新股表现亮眼 恒瑞医药涨超30%
news flash· 2025-05-23 04:07
金十数据5月23日讯,港股早盘震荡走高,恒指收涨0.58%,报23679.99点;科指收涨0.61%,报5283.69 点。盘面上,药品股领涨,影视出版板块涨幅居前,汽车股分化,黄金股走低,零售商板块下跌。个股 方面,叮当健康(09886.HK)涨15.6%,阿里影业(01060.HK)涨11%,中手游(00302.HK)、昭衍新药 (06127.HK)涨超10%,阅文集团(00772.HK)涨6.6%,哔哩哔哩(09626.HK)涨5.4%,比亚迪股份 (01211.HK)涨3.9%;周大福(01929.HK)跌4.5%,滔搏(06110.HK)跌9.7%。新股Mirxes-B(02629.HK)涨 27.9%,新股恒瑞医药(01276.HK)涨30.87%。中国卫生集团(00673.HK)复牌涨157%,折让28.6%配股引 入新投资者。 港股午评:新股表现亮眼 恒瑞医药涨超30% ...
额敏县市场监督管理局开展民生领域广告专项行动   
Zhong Guo Shi Pin Wang· 2025-05-21 11:21
Group 1 - The core viewpoint of the articles emphasizes the importance of strengthening advertising regulation in the livelihood sector to maintain a fair advertising market and protect consumer rights [1][2] - The regulatory focus is on key industries related to daily life, such as medical, pharmaceutical, and food sectors, aiming to combat false advertising and misleading consumer practices [1] - The regulatory approach includes a "double random, one public" platform for inspections, ensuring a systematic and transparent oversight process [1] Group 2 - A total of 27 business entities were inspected, resulting in 3 immediate rectification notices issued for non-compliant advertising content [2] - The next steps involve the local market supervision authority focusing on consumer protection and creating a safe consumption environment, while enhancing the integrity of the advertising market [2] - The initiative includes promoting legal awareness among business operators regarding advertising laws to strengthen industry self-discipline [1][2]